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Throughout the country, the number of lip biopsies being
performed by Medicare providers has decreased throughout the 7-
year period we evaluated. There was a similar percent decrease in
the number of biopsies being performed as in the number of
dermatologists performing said procedure. By contrast, there was a
much smaller percent decrease in average Medicare payment
amount per year for this procedure. Data was unavailable for
factors such as lesion morphology and differential diagnosis that
may have impacted provider decisions to biopsy or not to biopsy.
This data only accounted for Medicare patients and providers. This
data encourages further studies to be conducted focusing on
qualitative assessments of provider decision-making and to
evaluate whether similar trends persist over time. Further studies
should also be performed based on private insurances to see if
similar patterns exist in terms of compensation and whether similar
trends can be found among different insurance carriers.
Results
The remaining providers performing the procedure were family
medicine physicians, otolaryngologists, pediatricians, and plastic
surgeons, among others.
We evaluated the average Medicare payment amount per year for
this procedure to determine if there was correlation between fewer
procedures being performed and decreased compensation. We
found that over this 7-year period, payment only decreased by
about $2.80 ($91.28 in 2012 to $88.48 in 2018), signifying a
3.07% decrease in compensation (Figure 3).
The number of lip biopsies being performed in each of the four
regions of the United States was evaluated to account for major
shifts within a certain region. We found that from 2012 to 2018,
there were similar percent decreases in the number of biopsies
being performed per region. In the North, South, West, and
Midwest, there was a 56.55%, 64.63%, 53.38%, and 66.15%
decrease in biopsies, respectively, with no major inconsistencies
seen in any one region throughout the years (Figure 4). All data
had R2 values between 0.81 and 0.89. The South, however, did
account for the larger majority of total lip biopsies throughout this
time period, comprising about 60% of the total national biopsies.
Despite their large volume of procedures, the South still decreased
in biopsy count at a rate comparable to that of the other regions.
Methods
Results were imported from the Physician and Other Supplier
Public Use File within the MPUP database. Several queries were
designed in order to obtain lip biopsy information based on
specific qualifiers using HCPCS code 40490, which codes for
“Biopsy of lip”. The data was then analyzed via a spreadsheet
program to show changes in trends over the years. A query was
designed to analyze the total count of lip biopsy procedures per
year nationally. The average Medicare payment amount per
procedure each year, on a national scale inclusive of all specialties
was also analyzed. A separate query was designed to obtain only
the number of dermatologists performing this procedure each
year. All variations of these measures from 2012 to 2018 were
calculated and plotted. The only demographic data available by
CMS was each provider’s individual state of practice. To
demonstrate regional changes over time, providers’ states were
divided into 4 regions as categorized by the US Census Bureau
(Northeast, Southeast, West, and Midwest), then each region’s
biopsy count was plotted over the course of 7 years. All graphs
were created, and R2 values were calculated using a spreadsheet
program.
Results
From 2012 to 2018, the total number of lip biopsies performed in
the United States decreased steadily from 18,277 in 2012 to
6,945 in 2018, a 62.00% decrease with an R2 value of 0.88
(Figure 1).
In terms of provider type, dermatologists (MDs and DOs)
comprised about 90% of providers performing lip biopsies year
after year. As dermatologists were the primary provider type
performing this service, the number of dermatologists
documented as performing lip biopsies was calculated. The
number of dermatologists performing this procedure each year
decreased from 776 in 2012 to 315 in 2018, a 59.41% decrease
with an R2 value of 0.91 (Figure 2). Nurse practitioners and
physician assistants comprised between 6% and 12% of providers
performing the procedure each year, but CMS data did not
provide specific specialties for these providers, so their data was
excluded from the dermatologist count as we could not deduce
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AVERAGE MEDICARE PAYMENT AMOUNT PER LIP BIOPSY
Figure 3. Trend of average Medicare 
payment amount per lip biopsy
Biopsy of the lip is a procedure most used by dermatologists in
order to obtain histopathological evaluation of a lesion. It has
remained the definitive method of diagnosis for many pathologies,
including malignancy. However, although the incidence of lip
malignancy has been relatively unchanged since 2012, the number
of lip biopsies performed has not followed the same trend, but
rather steeply declined since1. In this study, the national trends in
lip biopsies are evaluated. The Medicare Provider Utilization and
Payment (MPUP) database was used to evaluate these practice


















NUMBER OF LIP BIOPSIES PER REGION
Northeast South West Midwest
Figure 4. Trend of number of lip 
biopsies per region
